In addition, the serum level of FA1 is elevated in some human pathological conditions including neurofibromatosis (Jensen et al., 1999), renal failure (10 times higher) (Jensen et al., 1997), and small cell lung cancer patients (10–1000 times higher) (Harken et al., 1999). This evidence concerns the gene DLK1 and acute kidney injury.